Published In
Turkish Journal of Gastroenterology
Volume 30 · Issue 9
Pages: 771-775
History
Published Online: September 15, 2019
Copyright © 2019 Aslı Çiftçibaşı Örmeci, Çağla Yıldız, Behnam Saberi, Merve Gürakar, Cem Şimşek, Ahmet Gürakar
Aslı Çiftçibaşı Örmeci
Division of Gastroenterology and Hepatology, Johns Hopkins University School of Medicine, Baltimore, MD, USA
Çağla Yıldız
Division of Gastroenterology and Hepatology, Johns Hopkins University School of Medicine, Baltimore, MD, USA
Behnam Saberi
Division of Gastroenterology and Hepatology, Transplant Hepatology, Johns Hopkins University School of Medicine, Baltimore, MD.
Merve Gürakar
Princeton University, Program in Global Health and Health Policy, Princeton, USA
Cem Şimşek
Division of Gastroenterology and Hepatology, Johns Hopkins University School of Medicine, Baltimore, MD, USA
Ahmet Gürakar
Division of Liver Transplantation Medicine/Hepatology, Nazih Zuhdi Transplantation Institute, Integris Baptist Medical Center, Oklahoma City, OK.
Çiftçibaşı Örmeci, A., Yıldız, Çağla, Saberi, B., Gürakar, M., Şimşek, C., & Gürakar, A. (2019). Usage of HCV viremic organs in liver transplantation to anti-HCV negative recipients: The current status and review of literature. Turkish Journal of Gastroenterology, 30(9), 771–775. https://doi.org/10.5152/tjg.2019.18656
Full Text
Full Text PDF
Full Text PDF
Abstract
Liver transplantation is the main curative therapy for end-stage liver disease. The number of transplanted organs is increasing globally. However, the number of available organs in the pool is insufficient, considering the excessive number of patients on the waiting list, which is a major concern for transplant programs. Hepatitis C infection (HCV) is a common indication for liver transplantation, and in recent years, a major progress has been made in its treatment with direct-acting antiviral (DAA) agents. HCV-positive livers have been transplanted to HCV-positive recipients for a long time. The high rate of sustained virologic response through DAA has brought new treatment options for the patients during the pre- and post-transplantation periods. Recently, there have been few reports of transplanting the available HCV-positive organs to HCV noninfected recipients. However, there is not yet an agreement on the optimal selection of patients who would benefit from such transplantation, and this has become a current topic of interest. Thus, we aim to review the current literature on this evolving topic.
Most read articles by the same author(s)
- Meral AKDOĞAN, Ahmet GÜRAKAR, Stan SHARAGO, Karim El-SAHWI, Jeff CARLSON RN, Anthony SEBASTIAN, Urooj AHMED, Harlan WRIGHT, Bakr NOUR, Unusual presentation of hepatic vascular tumors as fulminant hepatic failure , Turkish Journal of Gastroenterology: Vol. 13 No. 4 (2002): Turkish Journal of Gastroenterology
- Filiz Araz, Christine M. Durand, Ahmet Gürakar, New modalities in the treatment of HCV in pre and post - transplantation setting , Turkish Journal of Gastroenterology: Vol. 26 No. 3 (2015): Turkish Journal of Gastroenterology
- Nathalie H. Urrunaga, Jacqueline Garonzik Wang, Shane E. Ottmann, Andrew M. Cameron, Ahmet Gurakar, Benjamin Philosophe, Outcomes after live donor liver transplantation based on donor BMI , Turkish Journal of Gastroenterology: Vol. 30 No. Supplement 1 (2019): Volume 30 Issue S1 (2019)
- Cem Şimşek, Covering the Cover , Turkish Journal of Gastroenterology: Vol. 30 No. 10 (2019): Turkish Journal of Gastroenterology
- Cem Şİmşek, Considering the first randomized trial of peroral endoscopic myotomy versus surgical myotomy for achalasia , Turkish Journal of Gastroenterology: Vol. 31 No. 2 (2020): Turkish Journal of Gastroenterology
- Jihad Aljabban, Kamal Khorfan, Merve Gurakar, Nabeal Aljabban, Hussam Salhi, Maryam Panahiazar, Dexter Hadley, Behnam Saberi, From cirrhosis to hepatocellular carcinoma: An investigation into hepatitis C viral oncogenesis using meta-analysis , Turkish Journal of Gastroenterology: Vol. 30 No. Supplement 1 (2019): Volume 30 Issue S1 (2019)
Article Info
Published In
Journal
Turkish Journal of Gastroenterology
Volume / Issue
Volume 30 · Issue 9
Pages
771-775
History
Published Online
September 15, 2019
Copyright
Copyright (c) 2019 Aslı Çiftçibaşı Örmeci, Çağla Yıldız, Behnam Saberi, Merve Gürakar, Cem Şimşek, Ahmet Gürakar
Affiliations
Aslı Çiftçibaşı Örmeci
Division of Gastroenterology and Hepatology, Johns Hopkins University School of Medicine, Baltimore, MD, USA
Çağla Yıldız
Division of Gastroenterology and Hepatology, Johns Hopkins University School of Medicine, Baltimore, MD, USA
Behnam Saberi
Division of Gastroenterology and Hepatology, Transplant Hepatology, Johns Hopkins University School of Medicine, Baltimore, MD.
Merve Gürakar
Princeton University, Program in Global Health and Health Policy, Princeton, USA
Cem Şimşek
Division of Gastroenterology and Hepatology, Johns Hopkins University School of Medicine, Baltimore, MD, USA
Ahmet Gürakar
Division of Liver Transplantation Medicine/Hepatology, Nazih Zuhdi Transplantation Institute, Integris Baptist Medical Center, Oklahoma City, OK.
Cite this Article
Çiftçibaşı Örmeci, A., Yıldız, Çağla, Saberi, B., Gürakar, M., Şimşek, C., & Gürakar, A. (2019). Usage of HCV viremic organs in liver transplantation to anti-HCV negative recipients: The current status and review of literature. Turkish Journal of Gastroenterology, 30(9), 771–775. https://doi.org/10.5152/tjg.2019.18656
Outlines